• Proceedings of the Microbiological Society of Korea Conference
• /
• 2005.05a
• /
• pp.181.3-181
• /
• 2005

• Bulletin of the Korean Chemical Society
• /
• v.32 no.6
• /
• pp.2101-2104
• /
• 2011

• Proceedings of the Korean Society of Plant Pathology Conference
• /
• 2002.09a
• /
• pp.196.2-196
• /
• 2002

• Archives of Pharmacal Research
• /
• v.26 no.4
• /
• pp.312-316
• /
• 2003

The oriental herbal combination allergina has been shown to inhibit allergic inflammation. In the present study, we demonstrate that the oral administration of allergina markedly inhibits the progression of inflammatory diseases, such as graft-versus-host diseases (in the allogeneic bone marrow transplantation and the parent-into-F1 transplantation models), collagen-induced arthritis and sheep red blood cell-induced delayed type hypersensitivity. The immunosuppressive activity of allergina in vivo appears to be associated, at least in part, with the inhibition of tumor necrosis factor-a production. In conclusion, our results suggest that allergina could be useful as a immunosuppressive agent for the treatment of macrophage-related inflammatory disease.

• 한국약용작물학회:학술대회논문집
• /
• 2009.05a
• /
• pp.225-226
• /
• 2009

• Proceedings of the Microbiological Society of Korea Conference
• /
• 2002.10a
• /
• pp.197-200
• /
• 2002

• Proceedings of the Korean Society for Applied Microbiology Conference
• /
• 2005.06a
• /
• pp.117-121
• /
• 2005

• Proceedings of the Korean Society of Life Science Conference
• /
• 2005.04a
• /
• pp.121-121
• /
• 2005

• The Korea Genome Conference
• /
• 2004.07a
• /
• pp.47.2-47.2
• /
• 2004

• Proceedings of the Zoological Society Korea Conference
• /
• 1999.04a
• /
• pp.53.2-53
• /
• 1999

No Abstract, See Full Text